ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 83 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $76,372,209 | -3.1% | 2,937,948 | +6.7% | 0.01% | 0.0% |
Q1 2024 | $78,794,305 | +10.6% | 2,754,634 | +18.4% | 0.01% | 0.0% |
Q4 2023 | $71,210,442 | +19.5% | 2,326,876 | +4.9% | 0.01% | 0.0% |
Q3 2023 | $59,611,947 | -22.4% | 2,218,253 | +3.0% | 0.01% | -22.2% |
Q2 2023 | $76,777,786 | +45.4% | 2,153,050 | +3.6% | 0.01% | +28.6% |
Q1 2023 | $52,794,603 | +65854.5% | 2,078,527 | +5.3% | 0.01% | -36.4% |
Q4 2022 | $80,047 | -99.9% | 1,973,551 | +4.6% | 0.01% | +22.2% |
Q3 2022 | $62,378,000 | -4.3% | 1,887,397 | +1.9% | 0.01% | -10.0% |
Q2 2022 | $65,186,000 | -23.6% | 1,851,377 | -0.2% | 0.01% | -9.1% |
Q1 2022 | $85,308,000 | -29.1% | 1,854,931 | +2.1% | 0.01% | -26.7% |
Q4 2021 | $120,394,000 | +7.7% | 1,815,900 | +1.4% | 0.02% | 0.0% |
Q3 2021 | $111,773,000 | -25.4% | 1,790,377 | -1.0% | 0.02% | -28.6% |
Q2 2021 | $149,804,000 | +28.6% | 1,808,802 | +3.0% | 0.02% | +16.7% |
Q1 2021 | $116,474,000 | -5.6% | 1,756,510 | +9.2% | 0.02% | -14.3% |
Q4 2020 | $123,402,000 | +87.5% | 1,608,273 | +5.2% | 0.02% | +61.5% |
Q3 2020 | $65,805,000 | -2.0% | 1,528,228 | -1.7% | 0.01% | -7.1% |
Q2 2020 | $67,152,000 | +54.0% | 1,554,456 | +2.6% | 0.01% | +27.3% |
Q1 2020 | $43,605,000 | -76.0% | 1,515,643 | -47.1% | 0.01% | -42.1% |
Q4 2019 | $181,708,000 | +389.7% | 2,864,722 | +117.6% | 0.02% | +111.1% |
Q3 2019 | $37,107,000 | +9.2% | 1,316,785 | +2.7% | 0.01% | +12.5% |
Q2 2019 | $33,993,000 | +59.3% | 1,282,786 | +10.3% | 0.01% | +33.3% |
Q1 2019 | $21,335,000 | -13.8% | 1,162,703 | -41.7% | 0.01% | +50.0% |
Q4 2018 | $24,750,000 | +40.0% | 1,992,916 | +116.1% | 0.00% | -20.0% |
Q3 2018 | $17,677,000 | +48.7% | 922,163 | +5.5% | 0.01% | +25.0% |
Q2 2018 | $11,885,000 | +161.4% | 873,912 | +38.6% | 0.00% | +300.0% |
Q1 2018 | $4,546,000 | +105.1% | 630,631 | +4.7% | 0.00% | 0.0% |
Q4 2017 | $2,216,000 | -17.4% | 602,346 | -2.8% | 0.00% | 0.0% |
Q3 2017 | $2,683,000 | +196.1% | 619,730 | +10.7% | 0.00% | – |
Q2 2017 | $906,000 | -26.1% | 559,727 | -15.6% | 0.00% | -100.0% |
Q1 2017 | $1,226,000 | +23.3% | 663,062 | +3.4% | 0.00% | – |
Q4 2016 | $994,000 | -71.7% | 641,408 | +34.1% | 0.00% | -100.0% |
Q3 2016 | $3,516,000 | +58.6% | 478,392 | +14.8% | 0.00% | +100.0% |
Q2 2016 | $2,217,000 | – | 416,784 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |